6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: December 4, 2019
Period of Report: December 3, 2019
Accession Number: 0001157523-19-002316

View Document ↗ View on SEC.gov ↗